IP-10 Promotes Latent HIV Infection in Resting Memory CD4+ T Cells via LIMK-Cofilin Pathway
A major barrier to HIV eradication is the persistence of viral reservoirs. Resting CD4 + T cells are thought to be one of the major viral reservoirs, However, the underlying mechanism regulating HIV infection and the establishment of viral reservoir in T cells remain poorly understood. We have inves...
Saved in:
Published in | Frontiers in immunology Vol. 12; p. 656663 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
10.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A major barrier to HIV eradication is the persistence of viral reservoirs. Resting CD4
+
T cells are thought to be one of the major viral reservoirs, However, the underlying mechanism regulating HIV infection and the establishment of viral reservoir in T cells remain poorly understood. We have investigated the role of IP-10 in the establishment of HIV reservoirs in CD4
+
T cells, and found that in HIV-infected individuals, plasma IP-10 was elevated, and positively correlated with HIV viral load and viral reservoir size. In addition, we found that binding of IP-10 to CXCR3 enhanced HIV latent infection of resting CD4
+
T cells
in vitro.
Mechanistically, IP-10 stimulation promoted cofilin activity and actin dynamics, facilitating HIV entry and DNA integration. Moreover, treatment of resting CD4
+
T cells with a LIM kinase inhibitor R10015 blocked cofilin phosphorylation and abrogated IP-10-mediated enhancement of HIV latent infection. These results suggest that IP-10 is a critical factor involved in HIV latent infection, and that therapeutic targeting of IP-10 may be a potential strategy for inhibiting HIV latent infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Arik Cooper, National Institutes of Health (NIH), United States; Jennifer M. Zerbato, Peter Doherty Institute for Infection and Immunity, Australia These authors have contributed equally to this work This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology Edited by: Constantinos Petrovas, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2021.656663 |